CNE1000062X2
CNE1000062X2
SUNSHINE GUOJIAN PHARMACEUTICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.199.118.366 | 1.193.568.348 | 251.8% |
| Cost of Revenue | 332.952.490 | 304.344.731 | 9.4% |
| Gross Profit | 3.866.165.875 | 889.223.617 | 334.8% |
| 708.768.329 | 638.611.971 | 11.0% | |
| Operating Income | 3.157.397.547 | 250.611.646 | 1159.9% |
| Pretax Income | 3.318.537.477 | 707.655.325 | 368.9% |
| Net Income Common Stockholders | 2.899.304.587 | 704.579.055 | 311.5% |
| -- | -- | -- | |
| -- | -- | -- |